Athanasios Tsiouris1,2, Lynn Wilson3, Ala S Haddadin3, James J Yun3, Abeel A Mangi3. 1. Section of Cardiac Surgery, Yale University School of Medicine, New Haven, CT, USA. athtsiouris@hotmail.com. 2. Cardiothoracic Surgery, Providence Medical Center, 8919 Parallel Parkway, East Tower, Suite 580, Kansas City, KS, 66112, USA. athtsiouris@hotmail.com. 3. Section of Cardiac Surgery, Yale University School of Medicine, New Haven, CT, USA.
Abstract
OBJECTIVE: The aim of this study was to analyze risk factors and outcomes of vasoplegia after cardiac surgery based on our experience with almost 2000 cardiac operations performed at our institution. METHODS: We retrospectively analyzed patients who underwent cardiac surgery with cardiopulmonary bypass (CPB) between 2011 and 2013. Data were available for a total of 1992 patients. We defined vasoplegia as hypotension with persistently low systemic vascular resistance (<800 dyn/s/cm) and preserved Cardiac Index (>2.5). RESULTS: The rate of vasoplegia in our cohort was 20.3% (n = 405). The incidences of mild, moderate, and severe vasoplegia were 13.2, 5.7, and 1.5%, respectively. Factors that increased risk of vasoplegia included valve operations, heart transplants, dialysis-dependent renal failure, age >65, diuretic therapy, and recent myocardial infarction. B blocker therapy was protective against vasoplegia. CONCLUSION: Vasoplegic syndrome is still a frequently occurring adverse event following cardiac surgery. In high risk patients for vasoplegia, it may be sensible to proceed with preoperative volume loading (instead of diuresis), initiation of low dose vasopressin therapy if needed, and attempting to up titrate beta-blocker therapy.
OBJECTIVE: The aim of this study was to analyze risk factors and outcomes of vasoplegia after cardiac surgery based on our experience with almost 2000 cardiac operations performed at our institution. METHODS: We retrospectively analyzed patients who underwent cardiac surgery with cardiopulmonary bypass (CPB) between 2011 and 2013. Data were available for a total of 1992 patients. We defined vasoplegia as hypotension with persistently low systemic vascular resistance (<800 dyn/s/cm) and preserved Cardiac Index (>2.5). RESULTS: The rate of vasoplegia in our cohort was 20.3% (n = 405). The incidences of mild, moderate, and severe vasoplegia were 13.2, 5.7, and 1.5%, respectively. Factors that increased risk of vasoplegia included valve operations, heart transplants, dialysis-dependent renal failure, age >65, diuretic therapy, and recent myocardial infarction. B blocker therapy was protective against vasoplegia. CONCLUSION:Vasoplegic syndrome is still a frequently occurring adverse event following cardiac surgery. In high risk patients for vasoplegia, it may be sensible to proceed with preoperative volume loading (instead of diuresis), initiation of low dose vasopressin therapy if needed, and attempting to up titrate beta-blocker therapy.
Authors: J Cremer; M Martin; H Redl; S Bahrami; C Abraham; T Graeter; A Haverich; G Schlag; H G Borst Journal: Ann Thorac Surg Date: 1996-06 Impact factor: 4.330
Authors: Sidney C Smith; Ted E Feldman; John W Hirshfeld; Alice K Jacobs; Morton J Kern; Spencer B King; Douglass A Morrison; William W O'Neil; Hartzell V Schaff; Patrick L Whitlow; David O Williams; Elliott M Antman; Cynthia D Adams; Jeffrey L Anderson; David P Faxon; Valentin Fuster; Jonathan L Halperin; Loren F Hiratzka; Sharon Ann Hunt; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel Journal: Circulation Date: 2006-02-21 Impact factor: 29.690
Authors: M Strüber; J T Cremer; B Gohrbandt; C Hagl; M Jankowski; B Völker; H Rückoldt; M Martin; A Haverich Journal: Ann Thorac Surg Date: 1999-10 Impact factor: 4.330
Authors: David L S Morales; Mauricio J Garrido; John D Madigan; David N Helman; Joseph Faber; Mathew R Williams; Donald W Landry; Mehmet C Oz Journal: Ann Thorac Surg Date: 2003-03 Impact factor: 4.330
Authors: Rainer G Leyh; Theo Kofidis; Martin Strüber; Stefan Fischer; Karsten Knobloch; Bjoern Wachsmann; Christian Hagl; Andre R Simon; Axel Haverich Journal: J Thorac Cardiovasc Surg Date: 2003-06 Impact factor: 5.209
Authors: Walter Petermichl; Michael Gruber; Ina Schoeller; Kwahle Allouch; Bernhard M Graf; York A Zausig Journal: J Cardiothorac Surg Date: 2021-07-28 Impact factor: 1.637